Aurobindo's Lannett launches generic Advair Diskus in US
Aurobindo's Lannett launches generic Advair Diskus in US — Lannett Company LLC, a wholly-owned subsidiary of Aurobindo Pharma, has launched a generic version of Advair Diskus® in the United States. The product is indicated for asthma and COPD, competing with GlaxoSmithKline’s branded drug. This launch expands Aurobindo’s presence in the US respiratory market.
📊 STOCKS: $AUROPHARMA | 🏢 SECTOR: Pharma | #MEDIUMIMPACT #Pharma
This brief is AI-generated from public news sources for informational purposes only. Not investment advice. Always consult a SEBI-registered advisor before trading.